These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 27590685)

  • 1. Sentinel node biopsy in melanoma: Current controversies addressed.
    Madu MF; Wouters MW; van Akkooi AC
    Eur J Surg Oncol; 2017 Mar; 43(3):517-533. PubMed ID: 27590685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive power of serum S-100B for non-sentinel node positivity in melanoma patients.
    Damude S; Hoekstra HJ; Bastiaannet E; Muller Kobold AC; Kruijff S; Wevers KP
    Eur J Surg Oncol; 2016 Apr; 42(4):545-51. PubMed ID: 26831006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients.
    van der Ploeg AP; van Akkooi AC; Haydu LE; Scolyer RA; Murali R; Verhoef C; Thompson JF; Eggermont AM
    Eur J Cancer; 2014 Jan; 50(1):111-20. PubMed ID: 24074765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.
    Wevers KP; Murali R; Bastiaannet E; Scolyer RA; Suurmeijer AJ; Thompson JF; Hoekstra HJ
    Eur J Surg Oncol; 2013 Feb; 39(2):179-84. PubMed ID: 23137997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
    Ulmer A; Dietz K; Werner-Klein M; Häfner HM; Schulz C; Renner P; Weber F; Breuninger H; Röcken M; Garbe C; Fierlbeck G; Klein CA
    Eur J Cancer; 2018 Mar; 91():1-10. PubMed ID: 29316475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
    Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N
    Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
    Morton DL; Cochran AJ; Thompson JF; Elashoff R; Essner R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ;
    Ann Surg; 2005 Sep; 242(3):302-11; discussion 311-3. PubMed ID: 16135917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma.
    Wagner JD; Davidson D; Coleman JJ; Hutchins G; Schauwecker D; Park HM; Havlik RJ
    Ann Surg Oncol; 1999 Jun; 6(4):398-404. PubMed ID: 10379863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study.
    Zhong J; Zou Z; Hu T; Sun W; Wang C; Yan W; Luo Z; Liu X; Xu Y; Chen Y
    Clin Exp Med; 2023 Nov; 23(7):4003-4010. PubMed ID: 37300655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Completion lymph node dissection after a positive sentinel node: no longer a must?
    van der Ploeg AP; van Akkooi AC; Verhoef C; Eggermont AM
    Curr Opin Oncol; 2013 Mar; 25(2):152-9. PubMed ID: 23328628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
    van Akkooi AC; Nowecki ZI; Voit C; Schäfer-Hesterberg G; Michej W; de Wilt JH; Rutkowski P; Verhoef C; Eggermont AM
    Ann Surg; 2008 Dec; 248(6):949-55. PubMed ID: 19092339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
    Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
    J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.
    Feldmann R; Fink AM; Jurecka W; Rappersberger K; Steiner A
    Eur J Surg Oncol; 2014 Jan; 40(1):73-6. PubMed ID: 24075029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prediction tool incorporating the biomarker S-100B for patient selection for completion lymph node dissection in stage III melanoma.
    Damude S; Wevers KP; Murali R; Kruijff S; Hoekstra HJ; Bastiaannet E
    Eur J Surg Oncol; 2017 Sep; 43(9):1753-1759. PubMed ID: 28797756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.
    van der Ploeg AP; van Akkooi AC; Rutkowski P; Cook M; Nieweg OE; Rossi CR; Testori A; Suciu S; Verhoef C; Eggermont AM;
    Br J Surg; 2012 Oct; 99(10):1396-405. PubMed ID: 22961519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.
    van der Ploeg AP; van Akkooi AC; Schmitz PI; Koljenovic S; Verhoef C; Eggermont AM
    Eur J Cancer; 2010 Sep; 46(13):2414-21. PubMed ID: 20621467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.
    Verver D; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Eggermont AMM; Verhoef C; Grünhagen DJ
    Eur J Cancer; 2018 Jun; 96():25-33. PubMed ID: 29660597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
    Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
    Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
    Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
    Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.